Louis-Patrick Haraoui’s research focuses on the spread of antibiotic-resistant bacteria (ARB), a major global concern. Most research on the causes of rising rates of ARB focus on antibiotic abuse. While limiting antibiotic consumption is important, Haraoui’s research seeks to identify other less obvious factors to improve our ability to contain their spread. To do so, he studies ARB at the genetic level (the genes that code for resistance) and the social level (the human actions that advantage ARB). In doing so, he questions current assumptions about how we think about microbiomes (the collection of genes found in microbial communities) and evolution.
- Junior 1 Clinical Research Scholarship - Fonds de Recherche du Québec - Santé, 2020-2024
- Haraoui, L. P., Sparrow, A., Sullivan, R., Burci, G. L., Dewachi, O., & Abu-Sittah, G. (2019). Armed conflicts and antimicrobial resistance: a deadly convergence. AMR Control, 5.
- Semret, M., & Haraoui, L. P. (2019). Antimicrobial resistance in the tropics. Infectious Disease Clinics, 33(1), 231-245.
- Mulvey, M. R., Haraoui, L. P., & Longtin, Y. (2016). Multiple Variants of Klebsiella pneumoniae Producing Carbapenemase in One Patient. The New England journal of medicine, 375(24), 2408-2410.
CIFAR is a registered charitable organization supported by the governments of Canada, Alberta and Quebec, as well as foundations, individuals, corporations and Canadian and international partner organizations.